AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
- Booth number: 2
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. We are focused on helping patients in disease areas including oncology, cardiovascular, immunoscience and fibrosis. Each day, our employees work together for patients – it drives everything we do.
- Booth number: 3
For more than a century, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, MSD continues to be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.
- Booth number: 14
Immuno-oncology is a top priority for Merck KGaA, Darmstadt, Germany, and Pfizer Inc. Their global strategic alliance enables the companies to benefit from each other's strengths/capabilities and explore the potential of the anti-PD-L1 avelumab. The alliance jointly develops/commercializes avelumab, and is investigating it as a mono or combination therapy to treat cancer.
- Booth number: 11
At Boehringer Ingelheim we are taking cancer on. We are collaborating with the oncology community to deliver scientific breakthroughs to transform the lives of patients. Our primary focus is in lung and gastrointestinal cancers, with the goal of delivering breakthrough, first-in-class treatments that can help win the fight against cancer.
- Booth Number: 13a
Immuno-oncology is a top priority for Merck KGaA, Darmstadt, Germany, and Pfizer Inc. The global strategic alliance between Merck KGaA, Darmstadt, Germany, and Pfizer Inc., New York, US, enables the companies to benefit from each other’s strengths and capabilities and further explore the therapeutic potential of avelumab, an investigational anti-PD-L1 antibody initially discovered and developed by Merck KGaA, Darmstadt, Germany.
- Booth Number: 12
Takeda Pharmaceuticals International AG
Takeda Pharmaceutical Company Limited is a global, values-based, R&D-driven biopharmaceutical leader, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Gastroenterology (GI), Neuroscience and Rare Diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.
- Booth Number: 10a
Bayer is committed to delivering SCIENCE FOR A BETTER LIFE by advancing a portfolio of innovative treatments. The oncology franchise includes both marketed products and clinical development compounds which reflect the company’s approach to research: prioritizing targets and pathways with the potential to impact the way that cancer is treated.
- Booth Number: 16
For more than fifty years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world.
Novartis Oncology is a global leader in improving outcomes for patients. We seek to transform cancer care through distinctive scientific and clinical strategies focused on developing targeted, immuno-oncology and combination therapies to create more effective options for patients.
- Booth Number: 13b
Roche Pharma (Switzerland) Ltd.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and CNS diseases. Lung cancer is a major area of focus for Roche, with the objective to develop new approaches, medicines and tests that can help people with this deadly disease. With the combined strength in pharmaceuticals and diagnostics, Roche is dedicated to further drive personalized healthcare.
- Booth Number: 30
Biocartis aims to provide direct access to personalized medicine for patients worldwide by developing fully integrated, broadly applicable molecular diagnostics. Biocartis’ MDx Idylla™ platform is a fully automated sample-to-result, real-time Polymerase Chain Reaction system that offers accurate, highly reliable molecular information from virtually any biological sample in virtually any setting.
- Booth Number: 10b
BEACON Medicare Limited
BEACON Medicare Limited is a concern of BEACON Group and Global Marketing Partner of BEACON Oncology Limited. BEACON is the No-1 Oncology company and one of the leading pharma companies of Bangladesh. BEACON manufactures more than 150 life saving anti-cancer products which includes conventional chemotherapy, Monoclonal antibodies, Targeted therapies, Nano and Lyposomal preparations. After meeting the local demand, BEACON exports its medicines globally.
- Booth Number: 18
Daiichi Sankyo Group is dedicated to the creation of innovative pharmaceutical products to address unmet medical needs of patients. With over 100 years of scientific expertise and 15,000 employees around the world Daiichi Sankyo draw upon a robust pipeline of promising new medicines. Research and development is focused on oncology, immuno-oncology, pain management, neurodegenerative diseases, heart and kidney diseases, and other rare diseases.
- Booth Number: 10c
NeoGenomics specializes in cancer genetics testing and information services with the most comprehensive oncology-focused testing menus globally to diagnose and treat cancer. NeoGenomics operates CLIA certified laboratories serving the needs of pathologists, oncologists, academic centers, hospital systems, Pharma, and managed care organizations. Visit neogenomics.com to learn more about our global locations.
- Booth Number: 17
Thermo Fisher Scientific
Thermo Fisher Scientific is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. We support precision oncology progress and implementation with innovative technologies and service through our brands. We offer next generation sequencing tests for genomic profiling of solid and hematological tumors including liquid biopsy and immuno-oncology applications.
- Booth Number: 15
Amoy Diagnostics Co., Ltd.
Amoy Diagnostics Co., Ltd. (AmoyDx) is an R&D based manufacturer of genetic/genomic testing products and service provider for personalized healthcare, currently focusing on biomarker testing for precision oncology. AmoyDx has a rich portfolio of tests that focuses on detecting mutations and measuring gene expression in various sample types including FFPE cancer tissue, body fluids, and whole blood.
- Booth Number: 21
Standard Educational Grant Sponsor
Incyte Biosciences International Sarl
Incyte is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics.